Mr Thomas Mitchell, FRCS

Clinician Scientist Fellow

Tom Mitchell's research programme focusses on understanding how kidney tumours initiate, evolve and evade treatment. The motivation for this body of work is provided by the patients he treats as a Consultant Urologist at Addenbrooke's Hospital where he specialises in the surgical treatment of kidney cancer.

I am interested in deciphering how tumours evolve over many decades from normal healthy cells. Increasingly, my interest lies not only in understanding and modelling somatic mutations acquired in the developing tumour, but also how these cancer cells interact with their multi-cellular micro-environment. The over-arching aim of these approaches is to improve the clinical management of patients with cancer.

My timeline

• Cancer Research UK/ Royal College of Surgeons Clinician Scientist Fellowship, Wellcome Sanger Institute

• Honorary Consultant Urologist, Addenbrooke's Hospital

• FRCS (Urol): Fellowship of the Royal College of Surgeons of England

• Academic Clinical Lecturer, Cambridge University

• Honorary Specialist Registrar, Addenbrooke's Hospital

• Academic Clinical Fellow, Cambridge University

• Core Surgical Trainee, Gloucestershire NHS Foundation Trust

• Foundation Doctor, Gloucestershire NHS Foundation Trusts

• BMBCh, Bachelor of Medicine and Surgery, University of Oxford

• DPhil, Doctorate of Philosophy in Engineering Science, University of Oxford